---
document_datetime: 2023-09-21 17:31:26
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/lamzede-epar-all-authorised-presentations_en.pdf
document_name: lamzede-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.968185
conversion_datetime: 2025-12-30 20:45:26.673451
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number        | (Invented) name   | Strength   | Pharmaceutical Form              | Route of Administration   | Immediate Packaging   | Content         | Pack size   |
|------------------|-------------------|------------|----------------------------------|---------------------------|-----------------------|-----------------|-------------|
| EU/1/17/1258/001 | Lamzede           | 10 mg      | Powder for solution for infusion | Intravenous use           | Vial (glass)          | 10 mg (2 mg/mL) | 1 vial      |
| EU/1/17/1258/002 | Lamzede           | 10 mg      | Powder for solution for infusion | Intravenous use           | Vial (glass)          | 10 mg (2 mg/mL) | 5 vials     |
| EU/1/17/1258/003 | Lamzede           | 10 mg      | Powder for solution for infusion | Intravenous use           | Vial (glass)          | 10 mg (2 mg/mL) | 10 vials    |